ARCH Venture Fund IX, L.P. 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-13 3:45 pm Sale |
2022-08-12 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 13,552,310 10.200% |
-5,636,784 (-29.37%) |
Filing |
| 2022-05-10 5:05 pm Purchase |
2021-12-20 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 19,189,094 14.700% |
3,374 (+0.02%) |
Filing |
| 2022-01-10 5:02 pm Sale |
2021-12-20 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 19,185,720 14.700% |
-2,589,653 (-11.89%) |
Filing |
| 2021-07-12 5:02 pm Sale |
2021-06-22 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 21,775,373 16.700% |
-4,915,244 (-18.42%) |
Filing |
| 2021-04-14 5:23 pm Sale |
2021-03-30 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 26,690,617 20.900% |
-1,976,046 (-6.89%) |
Filing |
| 2020-07-29 3:50 pm Unchanged |
2020-07-08 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 28,666,663 23.000% |
0 (Unchanged) |
Filing |